Real World Study on the Efficacy and Safety of Apremilast in Chinese Patients With Moderate to Severe Plaque Psoriasis, a Multi Center, Prospective, Observational Trial（REACT）
Clinical trial NCT05863273 · COMPLETED
Trial details
- NCT number
- NCT05863273
- Sponsor
- First Hospital of China Medical University
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2023-05-22
- Primary completion
- 2025-02-10
- Enrollment
- 360
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.